[Chemotherapy of Hodgkin's disease]

Rev Prat. 1974 Oct 11;24(45):3957-60, 3963-4, 3967-8.
[Article in French]
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use
  • Drug Hypersensitivity
  • Drug Therapy, Combination
  • Hodgkin Disease / therapy*
  • Humans
  • Mechlorethamine / administration & dosage
  • Mechlorethamine / adverse effects
  • Mechlorethamine / therapeutic use
  • Podophyllotoxin / administration & dosage
  • Podophyllotoxin / adverse effects
  • Podophyllotoxin / therapeutic use
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Prednisone / therapeutic use
  • Procarbazine / administration & dosage
  • Procarbazine / adverse effects
  • Procarbazine / therapeutic use
  • Recurrence
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects
  • Vinblastine / therapeutic use
  • Vincristine / administration & dosage
  • Vincristine / adverse effects
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Podophyllotoxin
  • Prednisone